Volume 123, Issue 11 p. 1753-1760
Systematic Review

Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis

EOG van Vliet

EOG van Vliet

Obstetrics and Gynaecology, University Medical Centre Utrecht, Utrecht, The Netherlands

Contributed equally to the article.Search for more papers by this author
GH Dijkema

GH Dijkema

Obstetrics and Gynaecology, University Medical Centre Utrecht, Utrecht, The Netherlands

Contributed equally to the article.Search for more papers by this author
E Schuit

E Schuit

Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands

Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, The Netherlands

Department of Medicine, Stanford Prevention Research Centre, Stanford University, Stanford, CA, USA

Search for more papers by this author
KY Heida

KY Heida

Obstetrics and Gynaecology, University Medical Centre Utrecht, Utrecht, The Netherlands

Search for more papers by this author
C Roos

C Roos

Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Search for more papers by this author
JAM van der Post

JAM van der Post

Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, The Netherlands

Search for more papers by this author
EC Parry

EC Parry

Consultant Maternal Fetal Medicine Service, Auckland District Health Board, Auckland, New Zealand

Search for more papers by this author
L McCowan

L McCowan

Obstetrics and Gynaecology, University Medical Centre Auckland, Auckland, New Zealand

Search for more papers by this author
DJ Lyell

DJ Lyell

Obstetrics and Gynaecology, Stanford University Medical School, Stanford, CA, USA

Search for more papers by this author
YY El-Sayed

YY El-Sayed

Obstetrics and Gynaecology, Stanford University Medical School, Stanford, CA, USA

Search for more papers by this author
DB Carr

DB Carr

Obstetrics and Gynaecology, University of Washington, Washington, DC, USA

Search for more papers by this author
AL Clark

AL Clark

Obstetrics and Gynaecology, University of Washington, Washington, DC, USA

Search for more papers by this author
ZA Mahdy

ZA Mahdy

Obstetrics and Gynaecology, National University of Malaysia Medical Center, Cheras, Malaysia

Search for more papers by this author
M Uma

M Uma

Obstetrics and Gynaecology, National University of Malaysia Medical Center, Cheras, Malaysia

Search for more papers by this author
NC Sayin

NC Sayin

Obstetrics and Gynaecology, Trakya University, Edime, Turkey

Search for more papers by this author
GF Varol

GF Varol

Obstetrics and Gynaecology, Trakya University, Edime, Turkey

Search for more papers by this author
BW Mol

BW Mol

School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA, Australia

Search for more papers by this author
MA Oudijk

Corresponding Author

MA Oudijk

Obstetrics and Gynaecology, University Medical Centre Utrecht, Utrecht, The Netherlands

Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, The Netherlands

Correspondence: Dr MA Oudijk, Department of Obstetrics, Academisch Medisch Centrum, Postbus 22660, room H4-275, 1100 DD Amsterdam, The Netherlands. Email [email protected]Search for more papers by this author
First published: 23 August 2016
Citations: 25

Abstract

Background

Preterm birth is the leading cause of neonatal mortality and morbidity in developed countries. Whether continued tocolysis after 48 hours of rescue tocolysis improves neonatal outcome is unproven.

Objectives

To evaluate the effectiveness of maintenance tocolytic therapy with oral nifedipine on the reduction of adverse neonatal outcomes and the prolongation of pregnancy by performing an individual patient data meta-analysis (IPDMA).

Search strategy

We searched PubMed, Embase, and Cochrane databases for randomised controlled trials of maintenance tocolysis therapy with nifedipine in preterm labour.

Selection criteria

We selected trials including pregnant women between 24 and 366/7 weeks of gestation (gestational age, GA) with imminent preterm labour who had not delivered after 48 hours of initial tocolysis, and compared maintenance nifedipine tocolysis with placebo/no treatment.

Data collection and analysis

The primary outcome was perinatal mortality. Secondary outcome measures were intraventricular haemorrhage (IVH), necrotising enterocolitis (NEC), infant respiratory distress syndrome (IRDS), prolongation of pregnancy, GA at delivery, birthweight, neonatal intensive care unit admission, and number of days on ventilation support. Pre-specified subgroup analyses were performed.

Main results

Six randomised controlled trials were included in this IPDMA, encompassing data from 787 patients (n = 390 for nifedipine; n = 397 for placebo/no treatment). There was no difference between the groups for the incidence of perinatal death (risk ratio, RR 1.36; 95% confidence interval, 95% CI 0.35–5.33), intraventricular haemorrhage (IVH) ≥ grade II (RR 0.65; 95% CI 0.16–2.67), necrotising enterocolitis (NEC) (RR 1.15; 95% CI 0.50–2.65), infant respiratory distress syndrome (IRDS) (RR 0.98; 95% CI 0.51–1.85), and prolongation of pregnancy (hazard ratio, HR 0.74; 95% CI 0.55–1.01).

Conclusion

Maintenance tocolysis is not associated with improved perinatal outcome and is therefore not recommended for routine practice.

Tweetable abstract

Nifedipine maintenance tocolysis is not associated with improved perinatal outcome or pregnancy prolongation.